663 related articles for article (PubMed ID: 34081097)
1. Update on the Diagnosis and Treatment of POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes) Syndrome: A Review.
Khouri J; Nakashima M; Wong S
JAMA Oncol; 2021 Sep; 7(9):1383-1391. PubMed ID: 34081097
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and the long-term outcome of patients with atypical POEMS syndrome variant with undetectable monoclonal gammopathy.
He T; Zhao A; Zhao H; Cai H; Feng J; Zhang L; Cao X; Zhou D; Li J
Ann Hematol; 2019 Mar; 98(3):735-743. PubMed ID: 30612232
[TBL] [Abstract][Full Text] [Related]
3. Living with Polyneuropathy Organomegaly Endocrinopathy Monoclonal gammopathy Skin changes (POEMS) syndrome: a case study of healthcare experiences and quality of life.
Twigg J; Methley A; Lavin T; Dickinson G; Teager A
Disabil Rehabil; 2021 Aug; 43(17):2502-2510. PubMed ID: 31838877
[TBL] [Abstract][Full Text] [Related]
4. Skin Responses in Newly Diagnosed Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes (POEMS) Syndrome After Therapy With Low-Dose Lenalidomide Plus Dexamethasone.
Gao Y; Zhang S; Yang L; Li J; Liu Y; Wang T
Front Immunol; 2021; 12():681360. PubMed ID: 34025681
[TBL] [Abstract][Full Text] [Related]
5. Combined Therapy with Ixazomib, Lenalidomide, and Dexamethasone for Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome.
Suichi T; Misawa S; Sekiguchi Y; Shibuya K; Nakamura K; Kano H; Aotsuka Y; Otani R; Morooka M; Tsukamoto S; Takeda Y; Mimura N; Ohwada C; Sakaida E; Kuwabara S
Intern Med; 2022; 61(17):2567-2572. PubMed ID: 36047093
[TBL] [Abstract][Full Text] [Related]
6. A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome.
Li J; Huang XF; Cai QQ; Wang C; Cai H; Zhao H; Zhang L; Cao XX; Gale RP; Zhou DB
Am J Hematol; 2018 Jun; 93(6):803-809. PubMed ID: 29603764
[TBL] [Abstract][Full Text] [Related]
7. [POEMS syndrome: monoclonal plasma cell disorder with polyneuropathy].
Kamezaki K; Nagafuji K
Nihon Rinsho; 2007 Dec; 65(12):2235-7. PubMed ID: 18069266
[TBL] [Abstract][Full Text] [Related]
8. Plasma-cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome.
Miralles GD; O'Fallon JR; Talley NJ
N Engl J Med; 1992 Dec; 327(27):1919-23. PubMed ID: 1333569
[TBL] [Abstract][Full Text] [Related]
9. POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes) treated with autologous hematopoietic stem cell transplantation: a case report and literature review.
Arana C; Pérez de León JA; Gómez-Moreno G; Pérez-Cano R; Martín Hernández T
Am J Case Rep; 2015 Mar; 16():124-9. PubMed ID: 25726020
[TBL] [Abstract][Full Text] [Related]
10. Surgical revascularization for quasi-moyamoya disease associated with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome: a case report and literature review.
Kubota Y; Hanaoka Y; Koyama JI; Takahashi Y; Katoh N; Iwaya M; Fujii Y; Ogiwara T; Horiuchi T
Nagoya J Med Sci; 2023 Feb; 85(1):141-149. PubMed ID: 36923610
[TBL] [Abstract][Full Text] [Related]
11. [POEMS syndrome: Diagnosis, stratification, treatments].
Talbot A; Jaccard A; Arnulf B
Rev Med Interne; 2021 May; 42(5):320-329. PubMed ID: 33678446
[TBL] [Abstract][Full Text] [Related]
12. Paraproteinemia and neuropathy.
Koike H; Katsuno M
Neurol Sci; 2021 Nov; 42(11):4489-4501. PubMed ID: 34529193
[TBL] [Abstract][Full Text] [Related]
13. POEMS Syndrome: 2019 Update on diagnosis, risk-stratification, and management.
Dispenzieri A
Am J Hematol; 2019 Jul; 94(7):812-827. PubMed ID: 31012139
[TBL] [Abstract][Full Text] [Related]
14. POEMS syndrome: A multisystem clonal disorder.
Ali T; Qazilbash MH
Eur J Haematol; 2021 Jan; 106(1):14-18. PubMed ID: 32889731
[TBL] [Abstract][Full Text] [Related]
15. POEMS Syndrome with Biclonal Gammopathy and Renal Involvement.
Inoue K; Nagai K; Tsukada T; Iwase M; Sakata A; Ueda A; Yamagata K
Intern Med; 2022 Jul; 61(14):2191-2196. PubMed ID: 35283379
[TBL] [Abstract][Full Text] [Related]
16. Leave It to the Prose: A Case of POEMS Syndrome.
Samant S; Umpierrez De Reguerro A
Cureus; 2021 Oct; 13(10):e18664. PubMed ID: 34790444
[TBL] [Abstract][Full Text] [Related]
17. POEMS Syndrome: Therapeutic Options.
Jaccard A
Hematol Oncol Clin North Am; 2018 Feb; 32(1):141-151. PubMed ID: 29157615
[TBL] [Abstract][Full Text] [Related]
18. Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome.
Kuwabara S; Dispenzieri A; Arimura K; Misawa S; Nakaseko C
Cochrane Database Syst Rev; 2012 Jun; 2012(6):CD006828. PubMed ID: 22696361
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment with daratumumab, lenalidomide, and dexamethasone therapy followed by autologous stem cell transplantation for newly diagnosed polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes syndrome: a case report.
Taenaka R; Shimokawa S; Katayama A; Nagao T; Obara T; Nishimura N; Tsujimoto A; Kohno K; Aoki K; Ogawa R
J Med Case Rep; 2022 Aug; 16(1):311. PubMed ID: 35978379
[TBL] [Abstract][Full Text] [Related]
20. POEMS syndrome: 2017 Update on diagnosis, risk stratification, and management.
Dispenzieri A
Am J Hematol; 2017 Aug; 92(8):814-829. PubMed ID: 28699668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]